Can manipulation of differentiation conditions eliminate proliferative cells from a population of ES cell-derived forebrain cells?

por Precious, Sophie V., Kelly, Claire M., Allen, Nicholas D., Rosser, Anne E.
Publicado 2016

Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets

por Laprairie, Robert B, Bagher, Amina M, Precious, Sophie V, Denovan-Wright, Eileen M
Publicado 2015

Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?

por Precious, Sophie V., Zietlow, Rike, Dunnett, Stephen B., Kelly, Claire M., Rosser, Anne E.
Publicado 2017

Is the adult mouse striatum a hostile host for neural transplant survival?

por Roberton, Victoria H., Evans, Amy E., Harrison, David J., Precious, Sophie V., Dunnett, Stephen B., Kelly, Claire M., Rosser, Anne E.
Publicado 2013

Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model

por Precious, Sophie V., Smith, Gaynor A., Heuer, Andreas, Jaeger, Ines, Lane, Emma L., Dunnett, Stephen B., Li, Meng, Kelly, Claire M., Rosser, Anne E.
Publicado 2020

Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease

por Choompoo, Narawadee, Bartley, Oliver J.M., Precious, Sophie V., Vinh, Ngoc-nga, Schnell, Christian, Garcia, Ana, Roberton, Victoria H., Williams, Nigel M., Kemp, Paul J., Kelly, Claire M., Rosser, Anne E.
Publicado 2021